Zacks Research Has Pessimistic View of EverQuote Q2 Earnings

EverQuote, Inc. (NASDAQ:EVERFree Report) – Equities research analysts at Zacks Research cut their Q2 2026 EPS estimates for EverQuote in a note issued to investors on Thursday, April 9th. Zacks Research analyst Team now anticipates that the company will post earnings per share of $0.40 for the quarter, down from their previous estimate of $0.42. Zacks Research currently has a “Hold” rating on the stock. The consensus estimate for EverQuote’s current full-year earnings is $0.72 per share. Zacks Research also issued estimates for EverQuote’s Q1 2027 earnings at $0.37 EPS, Q2 2027 earnings at $0.32 EPS, Q1 2028 earnings at $0.49 EPS and FY2028 earnings at $2.40 EPS.

Other analysts have also recently issued reports about the stock. Weiss Ratings reiterated a “hold (c)” rating on shares of EverQuote in a research note on Thursday, January 22nd. Canaccord Genuity Group reduced their target price on shares of EverQuote from $33.00 to $28.00 and set a “buy” rating for the company in a research note on Tuesday, February 24th. Raymond James Financial reiterated an “outperform” rating and issued a $18.00 target price on shares of EverQuote in a research note on Tuesday, February 17th. B. Riley Financial reduced their target price on shares of EverQuote from $36.00 to $30.00 and set a “buy” rating for the company in a research note on Tuesday, February 24th. Finally, Wall Street Zen cut shares of EverQuote from a “strong-buy” rating to a “buy” rating in a research note on Saturday, April 4th. Six equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat, EverQuote presently has a consensus rating of “Moderate Buy” and an average target price of $23.83.

Read Our Latest Stock Report on EverQuote

EverQuote Stock Performance

EVER stock opened at $15.09 on Friday. The stock has a market cap of $543.69 million, a P/E ratio of 5.72 and a beta of 0.62. The firm has a 50 day simple moving average of $16.01 and a 200 day simple moving average of $21.45. EverQuote has a 52 week low of $13.93 and a 52 week high of $28.73.

EverQuote (NASDAQ:EVERGet Free Report) last posted its quarterly earnings results on Monday, February 23rd. The company reported $1.54 EPS for the quarter, topping the consensus estimate of $0.35 by $1.19. The business had revenue of $195.32 million during the quarter, compared to analysts’ expectations of $176.82 million. EverQuote had a net margin of 14.34% and a return on equity of 57.65%. The firm’s quarterly revenue was up 32.3% compared to the same quarter last year. During the same period last year, the company posted $0.33 earnings per share.

Institutional Trading of EverQuote

Institutional investors and hedge funds have recently modified their holdings of the company. Comerica Bank lifted its stake in shares of EverQuote by 235.4% in the third quarter. Comerica Bank now owns 1,100 shares of the company’s stock worth $25,000 after buying an additional 772 shares during the last quarter. Versant Capital Management Inc lifted its stake in shares of EverQuote by 108.9% in the third quarter. Versant Capital Management Inc now owns 1,153 shares of the company’s stock worth $26,000 after buying an additional 601 shares during the last quarter. Clearstead Advisors LLC lifted its stake in shares of EverQuote by 70.5% in the fourth quarter. Clearstead Advisors LLC now owns 1,997 shares of the company’s stock worth $54,000 after buying an additional 826 shares during the last quarter. NewEdge Advisors LLC acquired a new stake in shares of EverQuote in the third quarter worth $52,000. Finally, Jones Financial Companies Lllp lifted its stake in shares of EverQuote by 595.8% in the third quarter. Jones Financial Companies Lllp now owns 2,623 shares of the company’s stock worth $62,000 after buying an additional 2,246 shares during the last quarter. 91.54% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at EverQuote

In other EverQuote news, CEO Jayme Mendal sold 14,360 shares of EverQuote stock in a transaction that occurred on Friday, February 20th. The shares were sold at an average price of $14.98, for a total value of $215,112.80. Following the completion of the sale, the chief executive officer directly owned 541,777 shares in the company, valued at $8,115,819.46. The trade was a 2.58% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director John L. Shields sold 2,000 shares of EverQuote stock in a transaction that occurred on Monday, January 12th. The shares were sold at an average price of $25.73, for a total transaction of $51,460.00. Following the completion of the sale, the director owned 25,219 shares of the company’s stock, valued at $648,884.87. This trade represents a 7.35% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 34,456 shares of company stock worth $677,348 over the last ninety days. 25.52% of the stock is currently owned by insiders.

About EverQuote

(Get Free Report)

EverQuote, Inc operates an online insurance marketplace that connects consumers with insurance providers across the United States. Founded in 2011 and headquartered in Cambridge, Massachusetts, the company leverages proprietary technology to match individuals seeking coverage with insurers offering competitive rates. Since its initial public offering in 2020, EverQuote has focused on expanding its digital platform and enhancing the efficiency of its lead-generation processes.

The company’s core business centers on a quote-comparison engine for personal auto, home, and health insurance products.

Further Reading

Earnings History and Estimates for EverQuote (NASDAQ:EVER)

Receive News & Ratings for EverQuote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EverQuote and related companies with MarketBeat.com's FREE daily email newsletter.